Blog
Is MercadoLibre Stock a Buy Now?
MercadoLibre (NASDAQ: MELI) posted its first-quarter report on May 5. The Latin American e-commerce leader's revenue rose 63% year over year (YOY) to $2.25 billion, which beat analysts' estimates by
If You Invested $10,000 in Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today
When we look back on stock growth stories that tell of gargantuan returns, there are typically only a few people who had the foresight to invest at the beginning and reap the full benefits of a
Why Rivian and Palantir Are Falling in Monday's Stock Market Drop
Investors are dealing with a change in the mood of the market that many have never seen before. For years, the mentality on Wall Street has been that when share prices dip, it's a good time to buy
3 Stocks to Avoid This Week
My "three stocks to avoid" column sometimes catches a break with one bad stock sinking the gains elsewhere. The three names I figured were going to move lower for the week -- iRobot, Rent-A-Center
3 Dividend-Paying Tech Stocks to Buy in May
Dividends are underrated by technology investors. If you buy into a stock that consistently raises its dividend per share, it can provide a growing stream of cash that you can take home as income or
TackleAI CEO on Eliminating Bias from Financial Modeling
Bias can be found in a variety of businesses, including the financial industry. In this video clip from a Motley Fool Live interview, recorded on April 21, TackleAI CEO Sergio Suarez answers a few
Amplify Your Returns With This Stock
Digital optimization company Amplitude (NASDAQ: AMPL) recently reported its first-quarter 2022 earnings on May 4. Its software helps companies gather insights on their digital products, like data
Could Novavax Stock Help You Retire a Millionaire?
Many investors get in on the stock market to accumulate enough capital for their golden years, and with good reason. With enough patience and discipline, investing in stocks can help the average
How Will Your Social Security Stack Up to the $4,194 Max?
The wealthiest Social Security beneficiaries can expect $4,194 a month -- or over $50,000 this year -- from the program, but obtaining a benefit this size is no easy feat. Patience and a high income
Valuing ETFs, Buying Stocks for Kids, and More
In this podcast, Motley Fool analysts John Rotonti and Robert Brokamp answer questions about investing. Got a question for the Motley Fool Money podcast? Call our voice mail: 703-254-1445.
To catch
Can This Top Auto Stock Double Your Money in 5 Years?
Doubling your money in the stock market in five years implies an annualized return of roughly 15%. No matter how you look at it, this type of performance would be exceptional, and it even exceeds
Is a $1 Million Nest Egg Enough for Retirement?
Different people establish different savings goals when it comes to retirement. But you'll often hear people say that $1 million in savings is what it takes to retire comfortably.
Now the good news
My Top Dividend Stock to Buy in May (and It's Not Even Close)
In the first third of 2022, the S&P 500 fell by 13.3% and the Nasdaq Composite suffered a painful 21.2% decline. Investors felt the pain and market volatility is on the upswing amid uncertainty
3 Top Stocks to Buy in May
After a rough first quarter of the year, investors are hoping May can bring better results. The first five trading days of May were very volatile but the S&P 500 ended the week down only 0.21%. Many
My 2 Best Growth Stocks to Buy and Hold in May 2022 (and Beyond)
The S&P 500 Growth index has fallen sharply in recent months, weighed down by fears surrounding high inflation, geopolitical conflict, and rising interest rates. Even so, the index is up 260% over
This Alphabet Initiative Will Reward Shareholders Massively Over the Long Run
Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) is one of the world's most dominant companies. Its two largest divisions, the Google search engine and YouTube, have a market share of 86% and 76% in their
Is Vertex Pharmaceuticals' Billion-Dollar Business Getting Even Bigger?
Investors have been focusing on what's next for Vertex Pharmaceuticals (NASDAQ: VRTX) for quite a while. The company's main business of cystic fibrosis (CF) treatments has brought in billions. But
AI CEO: These 2 Industries Lead, As 1 Falls Behind
In this video clip from a Motley Fool Live interview, recorded on April 21, TackleAI CEO Sergio Suarez answers a question from Fool.com contributor Rachel Warren about the industries that have been
3 Safe Stocks to Buy That Are Crushing the Market
When will the market turmoil end? Unfortunately, no one really knows. There's no end in sight right now to high inflation, rising interest rates, and the continuing conflict in Ukraine. All of these
Want to Make $100,000 in Passive Income? Here's a Ridiculously Easy Way to Do It
Time is money. If you're not spending your time making enough money to support your lifestyle, you'll need to make money another way.
That's where passive income comes into play. It puts the money
How I'd Invest $50,000 for Retirement If I Had To Start From Scratch
One of the best things you can do when investing for retirement is start. There are thousands of companies and exchange-traded funds (ETFs) you can invest in, but for most people, they can
Nasdaq Bear Market: 3 No-Brainer Stocks to Buy During the Sell-Off
Whether you're a relatively new investor or have been putting your money to work on Wall Street for decades, it's been a challenging environment.
Since hitting their all-time closing highs in early
Stock Market Crash: 3 Absolute Bargains Just Begging to Be Bought
Buckle up, because volatility is back in a big way on Wall Street.
This past Thursday, May 5, just a day after the Federal Reserve increased interest rates by their largest amount in two decades (50
3 Things That Might Happen If You Claim Social Security Early
When it comes to signing up for Social Security, you get choices. You can file for benefits as early as age 62. But you're not entitled to your full monthly benefit until full retirement age (FRA)
Why Did Salesforce.com Fall 17% in April?
Shares of Salesforce.com (NYSE: CRM) dropped 17.1% in April as part of a growth-stock sell-off. Rising interest rates are pulling capital away from riskier assets, while investors are starting to


